Relating to quarantine leave for certain public safety employees.
Relating to prior authorization for prescription drug benefits related to the treatment or prevention of infectious diseases.
Relating to infection prevention and control programs and other measures for communicable diseases at certain long-term care facilities; authorizing an administrative penalty.
Relating to prohibitions on the provision to certain children of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and on the use of public money or public assistance to provide those procedures and treatments.
Relating to certain claims for benefits, compensation, or assistance by certain public safety employees and survivors of certain public safety employees.
Relating to the right to choose medical treatments and certain control measures and to the imposition of isolation or quarantine control measures.
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Relating to prohibitions on the provision to certain children of procedures and treatments for gender transitioning, gender reassignment, or gender dysphoria and on the use of public money or public assistance to provide those procedures and treatments.
Relating to the treatment of and education on sickle cell disease and the sickle cell task force.
Relating to prior authorization for prescription drug benefits related to the treatment of autoimmune diseases and certain blood disorders.